Liver Resection With Selective Hepatic Vascular Exclusion

Siyuan Fu(Nanjing University of Posts and Telecommunications), Weiping Zhou(Shenyang Medical College), Eric C. H. Lai(Second Military Medical University), Yuan Yang(Wenzhou Medical University), Aijun Li(Second Military Medical University), Yu-Min Sun(Second Military Medical University), Ze‐Ya Pan(Second Military Medical University), Mengchao Wu(Second Military Medical University), Wan Yee Lau(Chinese University of Hong Kong)
Annals of Surgery
April 1, 2009
10.1097/sla.0b013e31819ed212
Cited by 22

Related Papers

Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial
|The Lancet|2004|895
A Randomized Phase III Study of Doxorubicin Versus Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) Combination Chemotherapy for Unresectable Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2005|591
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma
|JAMA Surgery|2018|546
Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients.
|PubMed|1999|519
Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: A RCT
|Journal of Hepatology|2014|335